🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

322 results for “Hospital Authority, Hong Kong” Clear

  1. 3 % Minoxidil lotion

    Hospital Authority, Hong Kong

    Beard Enhancement

    approved small molecule completed

    1 trial

  2. 6-month clopidogrel therapy

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  3. Alendronate

    Hospital Authority, Hong Kong

    Non-Traumatic Osteonecrosis

    approved small molecule active

    1 trial

  4. Allopurinol Tablet 300 mg

    Hospital Authority, Hong Kong

    Kidney Calculi

    approved small molecule completed

    1 trial

  5. Aripiprazole

    Hospital Authority, Hong Kong

    First Episode Psychosis

    approved small molecule completed

    1 trial

  6. Bismuth-based susceptibility-guided treatment

    Hospital Authority, Hong Kong

    Helicobacter Pylori

    approved small molecule completed

    1 trial

  7. Breeze2 glucometer

    Hospital Authority, Hong Kong

    Diabetes

    approved other active

    1 trial

  8. Bupivacaine

    Hospital Authority, Hong Kong

    Pain

    approved small molecule completed

    1 trial

  9. Byfavo

    Hospital Authority, Hong Kong

    Bronchoscopy

    approved small molecule completed

    1 trial

  10. Chlorhexidine gluconate

    Hospital Authority, Hong Kong

    Liver Tumors

    approved small molecule completed

    1 trial

  11. Combination Cinacalcet with Vitamin D analogue

    Hospital Authority, Hong Kong

    Secondary Hyperparathyroidism

    approved small molecule active

    1 trial

  12. Continuos epidural infusion

    Hospital Authority, Hong Kong

    Analgesia, Epidural

    approved other active

    1 trial

  13. Cook balloon uterine stent

    Hospital Authority, Hong Kong

    Intrauterine Adhesion

    approved other completed

    1 trial

  14. Dexamethasone and N-acetylcysteine (NAC)

    Hospital Authority, Hong Kong

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  15. Dexmedetomidine

    Hospital Authority, Hong Kong

    Thyroid Diseases

    approved small molecule active

    1 trial

  16. Dextrose 5%

    Hospital Authority, Hong Kong

    End-Stage Kidney Disease

    approved small molecule active

    1 trial

  17. Etomidate

    Hospital Authority, Hong Kong

    Choledocholithiasis

    approved small molecule completed

    1 trial

  18. Finerenone

    Hospital Authority, Hong Kong

    Heart Failure and Preserved Ejection Fraction

    approved small molecule active

    1 trial

  19. Forsteo

    Hospital Authority, Hong Kong

    Spine Deformity

    approved small molecule active

    1 trial

  20. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial

  21. Intraosseous

    Hospital Authority, Hong Kong

    Cardiac Arrest

    approved other completed

    1 trial

  22. Intraosseous Morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    approved other active

    1 trial

  23. Ixekizumab

    Hospital Authority, Hong Kong

    Plaque Psoriasis

    approved mab active

    1 trial

  24. LNG-IUS

    Hospital Authority, Hong Kong

    Endometriosis

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources